Related Experiment Video
Updated: Oct 26, 2025

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease
Lini Jin1, Binfeng Yu1, Ines Armando2
1Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Institute of Nephrology, Zhejiang University, Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, Zhejiang, China.
Abstract:
The integrity and function of mitochondria are essential for normal kidney physiology. Mitochondrial DNA (mtDNA) has been widely a concern in recent years because its abnormalities may result in disruption of aerobic respiration, cellular dysfunction, and even cell death. Particularly, aberrant mtDNA copy number (mtDNA-CN) is associated with the development of acute kidney injury and chronic kidney disease, and urinary mtDNA-CN shows the potential to be a promising indicator for clinical diagnosis and evaluation of kidney function. Several lines of evidence suggest that mtDNA may also trigger innate immunity, leading to kidney inflammation and fibrosis. In mechanism, mtDNA can be released into the cytoplasm under cell stress and recognized by multiple DNA-sensing mechanisms, including Toll-like receptor 9 (TLR9), cytosolic cGAS-stimulator of interferon genes (STING) signaling, and inflammasome activation, which then mediate downstream inflammatory cascades. In this review, we summarize the characteristics of these mtDNA-sensing pathways mediating inflammatory responses and their role in the pathogenesis of acute kidney injury, nondiabetic chronic kidney disease, and diabetic kidney disease. In addition, we highlight targeting of mtDNA-mediated inflammatory pathways as a novel therapeutic target for these kidney diseases.
Insights
Mitochondrial DNA (mtDNA) abnormalities contribute to kidney disease by triggering inflammation. Targeting these pathways offers a promising therapeutic strategy for acute and chronic kidney conditions.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Mitochondrial integrity is crucial for kidney function.
- Mitochondrial DNA (mtDNA) abnormalities, such as aberrant copy number (mtDNA-CN), are linked to kidney injury and disease.
- Urinary mtDNA-CN shows potential as a diagnostic biomarker for kidney function.
Purpose of the Study:
- To review the role of mitochondrial DNA (mtDNA) in kidney inflammation and fibrosis.
- To summarize mtDNA-sensing pathways involved in kidney pathogenesis.
- To highlight therapeutic strategies targeting mtDNA-mediated inflammation in kidney diseases.
Main Methods:
- Review of existing literature on mtDNA, innate immunity, and kidney disease.
- Analysis of mechanisms by which extracellular mtDNA triggers inflammatory responses.
- Examination of the role of mtDNA sensing pathways (TLR9, cGAS-STING, inflammasomes) in kidney pathophysiology.
Main Results:
- Mitochondrial DNA (mtDNA) released under stress activates innate immune sensing pathways.
- These pathways, including Toll-like receptor 9 (TLR9) and cGAS-STING, mediate kidney inflammation and fibrosis.
- Aberrant mtDNA copy number (mtDNA-CN) is associated with acute kidney injury and chronic kidney disease.
Conclusions:
- Mitochondrial DNA (mtDNA) plays a significant role in the pathogenesis of various kidney diseases.
- Targeting mtDNA-mediated inflammatory pathways presents a novel therapeutic avenue for kidney disorders.
- Further research into mtDNA-sensing mechanisms can lead to improved diagnostics and treatments for kidney conditions.
More Related Videos
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

